Estrogen-induced genes in breast cancers and their medical applications;Gènes induits par les estrogènes dans les cancers du sein, et leur intérêt médical

Bulletin de l'Academie Nationale de Medecine

Volumn 183, Issue 5, 1999, Pages 955-968

  Rochefort, Henri ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

BREAST TUMOR; CANCER INVASION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METASTASIS; PHYSIOLOGY; REVIEW;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN;

EID: 0032612554     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. PIKE M.C., KRAILO M.D., HENDERSON B.E., CASAGRANDE J.T., HOEL D.G. - « Hormonal » risk factors, « breast tissue age »and the age-incidence of breast cancer. Nature, 1983, 303, 767-770.
2. Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and hormone replacement therapy : collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 441 women without breast cancer. Lancet, 1997, 350, 1047-1059.
3. HILL C., DOYON F. - La mortalité par cancer en France. Médecine/Sciences, 1997, 13, 1172-1175.
4. OSBORNE C.K. - Tamoxifen in the treatment of breast cancer. New Engl. J. Med., 1998, 339, 1609-1618.
5. SOULE H.D., VASQUEZ A., LONG A., ALBERT S., BRENNAN M. - A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 1973, 51, 1409-1413.
6. WESTLEY B., ROCHEFORT H. - A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell, 1980, 20, 353-362.
7. ROCHEFORT H., COEZY E., JOLY E., WESTLEY B., VIGNON F. - Hormonal control of breast cancer in cell culture. In Hormones and Cancer, sous la dir. de S. Iacobelli, R.J.B. King, H.R. Lindner et M.E. Lippman. - New York : Raven Press, 1980, 21-29.
8. DICKSON R.B., MACMANAWAY M.E., LIPPMAN M.E. - Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science, 1986, 232, 1540-1544.
9. WESTLEY B., MAY F.E.B., BROWN A.M.C., KRUST A., CHAMBON P., LIPPMAN M.E., ROCHEFORT H. - Effects of antiestrogens on the estrogen-regulated pS2 RNA, and the 52-k and 160-kilodalton proteins in MCF7 cells and two tamoxifen resistant sublines. J. Biol. Chem., 1984, 259, 10030-10035.
10. VIGNON F., CAPONY F., CHAMBON M., FREISS G., GARCIA M., ROCHEFORT H. - Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52K protein. Endocrinology, 1986, 118, 1537-1545.
11. THORPE S.M., ROCHEFORT H., GARCIA M., FREISS G., CHRISTENSEN I.J., KHALAF F., PAOLUCCI B., PAU, RASMUSSEN B.B., ROSE C. - Association between high concentrations of 52K cathepsin-D and poor prognosis in primary breast cancer. Cancer Res., 1989, 49, 6008-6014.
12. ROCHEFORT H., CAPONY F., GARCIA M. - Cathepsin D : A protease involved in breast cancer metastasis. In Cancer and Metastasis Reviews. - Netherlands : Kluwer Academic Publishers, 1990, 9, 321-331.
13. Rio M.C., BELLOCQ J.P., DANIEL J.Y. et al. - Breast cancer-associated pS2 protein : synthesis and secretion by normal stomach mucose. Science, 1988, 241, 705-708.
14. ROCHEFORT H. - Editorial : The prognostic value of cathepsin D in breast cancer. A long road to the clinic. Eur. J. Cancer, 1996, 32A, 7-8.
15. FERRANDINA G., SCAMBIA G., BARDELLI F., PANICI B., MANCUSO S., MESSORI A. - Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients : a meta-analysis. Br. J. Cancer, 1997, 76, 661-666.
16. GIAMACHI D., SOLANAS M., CHAILLEUX C, AUGEREAU P., VIGNON F., ROCHEFORT H., RICHARD-FOY H. - Chromatin structure of the regulatory regions of pS2 and cathepsin-D genes in hormone-dependent and independent breast cancer cell lines. Oncogene, 1999, 18, 533-541.
17. CAVAILLES V., AUGEREAU P., ROCHEFORT H. - Cathepsin D gene is controlled by a mixed promoter and estrogens stimulate only TATA dependent transcription in breast cancer cells. Proc. Natl. Acad. Sci. USA, 1993, 90, 203-207.
18. GARCIA M., DEROCQ D., PUJOL P., ROCHEFORT H. -Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene, 1990, 5, 1809-1814.
19. LIAUDET E., DEROCQ D., ROCHEFORT H., GARCI A M. - Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Differ., 1995, 6, 1045-1052.
20. ROCHEFORT H., LIAUDET-COOPMAN E. - Cathepsin D in cancer metastasis : a protease and a ligand. Acta Pathol. Microbiol. Immunol. Scand., 1999, 107, 86-95.
21. CLINTON G.M., ROUGEOT C., DERANCOURT J., ROGER P., DEFRENNE A. GODYNA S., ARGRAVES W.S., ROCHEFORT H. - Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. Proc. Natl. Acad. Sci. USA, 1996, 93, 316-320.
22. ROGER P., PUJOL P., LUCAS A., BALDET P., ROCHEFORT H. Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors. Am. J. Pathol., 1998, 153, 1579-1588.
23. FIDLER I.J., GERSTEN D.M., HART I.R. - The biology of cancer invasion and metastasis. Adv. Cancer Res., 1978, 28, 149-250.
24. GARCIA M., DEROCQ D., FREISS G., ROCHEFORT H. - Activation of estrogen receptor transfected in a receptor negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc. Natl. Acad. Sci. USA, 1992, 89, 11538-11542.
25. HAYASHIDO Y., LUCAS A., ROUGEOT C., GODYNA S., ARGRAVES W.S., ROCHEFORT H. -Estradiol and fibulin-1 inhibit motility of human ovarian and breast cancer cells induced by fibronectin. Int. J. Cancer, 1998, 75, 654-658.
26. ROCHEFORT H., PLATET N., HAYASHIDO Y., DEROCQ D., LUCAS A., CUNAT S., GARCIA M. Estrogen receptor mediated inhibition of cancer cell invasion and motility. An overview. J. Steroid Biochem. Mol. Biol., 1998, 65, 163-168.
27. SHEIKH M.S., GARCIA M., PUJOL P., FONTANA J.A., ROCHEFORT H. - Why are oestrogen-receptor-negative breast cancers more aggressive than oestrogen-receptor-positive breast cancer ? Invasion Metastasis, 1994, 14, 329-336.
28. PLATET N., CUNAT S., CHALBOS D., BONNET S., DEROCQ D., ROCHEFORT H., GARCIA M. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Soumis pour publication.
29. PRICE J.E., POLYZOS A., ZHANG R.D., DANIELS M.D. - Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res., 1990, 50, 717-721.